Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
RuiYi, iHuman Enter Partnership for New Antibodies Targeting GPCR... 6/12/2014
Chi-Med Initiates Phase II Clinical Trial for NSCLC Cancer Drug C... 6/6/2014
Review of Antibody Drug-Related Patent Applications in China 6/4/2014
Hengrui Medicine Gets Clinical Trial Approval for Class 1.1 New A... (free) 5/15/2014
Anke Bio's Long-acting Interferon Approved for Clinical Trials 5/13/2014
SIMM and Van Andel Researchers Discover Novel Glucocorticoids 5/6/2014
Recently Approved and To-Be-Approved New Drugs (Q1/2014) 3/31/2014
Guangzhou Pharma Contracts Research Team for Class 1.1 New Antica... 3/28/2014
SillaJen, Transgene and Lee's Pharma Confirm Clinical Development... 3/26/2014
NHFPC and Army Health Department Initiate Application for State f... 3/21/2014
CFDA Approves First Targeted-Drug-Delivery Stent (free) 3/21/2014
Chinese Medicine under Research for Pancreatic Cancer 3/20/2014
Hua Medicine Reports Positive Phase 1a Data for Novel Glucokinase... 3/19/2014
CDE Review of Class 1 New Drug Applications Nearly Doubled in 201... 3/2/2014
Shanghai Anew Pharma Completes Preclinical Study of Oncology Drug... 3/2/2014
Page:2/2    Total number of articles:45  :[1][2]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links